Date of Award
Chemistry & Biochemistry
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer that originates from glial cells, which make up the supportive tissue surrounding neurons. Temozolomide (TMZ) is the current chemotherapeutic drug administered to treat GBM as it works to inhibit the growth of the cancer cells. This research study focused on developing a method for synthesizing novel hybrid compounds that combines TMZ with various fatty acids known to have anticancer properties, forming a series of imide compounds with potential chemotherapeutic effects. Before synthesizing the compounds, various methods for synthesizing an imide from a primary amide were tested to ensure that TMZ and fatty acids would successfully react with each other to form the novel hybrid compounds. Once the novel hybrid compounds are synthesized, they will be tested for their anticancer properties on glioblastoma cells.
Pakkianathan, Janice, "Synthesis of Novel Temozolomide-Fatty Acid Imide Hybrid Compounds for the Chemotherapeutic Treatment of Glioblastoma Multiforme" (2020). Honors Theses. 251.
Glioblastoma multiforme; Imides
Presentation Record URL
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.